Vitamins and antioxidants: Topical and systemic

Vitiligo

Volumn , Issue , 2010, Pages 369-374

  Picardo, Mauro ^a   Dell'Anna, Maria Lucia ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872847716     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-69361-1_43     Document Type: Chapter

References (20)

1. Akyol M, Celik VK, Ozcelik S et al (2002) The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. Eur J Dermatol 12:24-26
2. Cormane RH et al (1985) Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 277:126-130
3. Dell'Anna ML, Mastrofrancesco A, Sala R et al (2007) Anrtioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 32:631-636
4. Dell'Anna ML, Picardo M (2006) A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res 19:406-411
5. 2): potential and pitfalls. J Invest Dermatol 126:2576-2582
6. Hercberg S, Ezzedine K, Guinot C et al (2007) Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 137:2098-2105
7. Juhlin L, Olsson MJ (1997) Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol 77:460-462
8. Middelkamp MA, Bos JD, Riuz-Diaz F et al (2007) Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized doubleblind placebo-controlled study. JEADV 21:942-950
9. Montes LF, Diaz ML, Lajous J et al (1992) Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis 50:39-42
10. Parsad D, Pandhi R, Juneja A (2002) Effectiveness of oral Gingko biloba in treating limited, slowly spreading vitiligo. Clin Exp Dermatol 28:285-287
11. Patel DC, Evans AV, Hawk JL (2002) Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open single-center study. Clin Exp Dermatol 27:641-644
12. Reyes E, Jaen P, de las Heras E et al (2006) Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci 41:213-216
13. Rojas-Urdaneta JE, Poleo-Romero AG (2007) Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo. Invest Clin 48:21-31
14. Shaker OG, El-Tahlawi S M R (2008) Is there a relationship between homocysteine and vitiligo? Br J Dermatol 159:720-724
15. Schallreuter KU, Bahadoran P, Picardo M et al (2008) Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcuim imbalance, or what else. Exp Dermatol 17:139-60
16. Schallreuter KU, Kruger C, Wurfel C et al (2008) From basic research to bedside: efficacy of topical treatment with pseudo catalase PC-KUS in 71 children with vitiligo. Int J Dermatol. 188:215-218
17. Schallreuter KU, Moore J, Behrens-Williams S, et al (2002). Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 41:482-487.
18. Schallreuter KU, Wood JM, Lemke KR et al (1995) Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatol 190:223-229
19. Siddiqui AH, Stolk L M L, Bhaggoe R et al (1994) L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatol 188:215-218
20. Tjioe M et al (2002) Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venerol 82:369-372